The game changing DTP Combination Vaccine evolution to improve VCR.

Speciality: All Speciality


Speaker:

Dr. Suhas Prabhu | Consultant Pediatrician

Dr. Denis Macina | Graduated with an MSc in Immunology from Universite Laval, Quabec

Description:

A warm welcome to all the medical professionals in this interesting session on The game changing DTP Combination Vaccine evolution to improve VCR.
The DTP (Diphtheria, Tetanus, and Pertussis) combination vaccine has been a cornerstone of childhood immunization programs worldwide. Its evolution marks significant advancements in improving vaccine coverage rates (VCR), ensuring broader protection against these serious infectious diseases.
Over the years, the DTP vaccine has undergone several modifications to enhance its efficacy and safety. Initially, whole-cell pertussis vaccines were used, which, although effective, were associated with higher rates of adverse reactions. The development of acellular pertussis vaccines (DTaP) offered a safer alternative with fewer side effects, leading to increased acceptance and higher vaccination rates.
Research is being conducted to develop next-generation vaccines that offer even broader protection with fewer doses. Additionally, efforts to educate communities and address vaccine hesitancy are essential to further improve VCR and sustain the gains achieved in controlling these preventable diseases.
Therefore, get an overall knowledge of the game changing DTP combination vaccine evolution to improve VCR.
 

See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

2.

Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

Prostate cancer 'is not a death knell': Early detection and personalized care improve outcomes, study shows

5.

Two medications might work better for breast cancers that are resistant to one.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot